FLRT Proteins Are Endogenous Latrophilin Ligands and Regulate Excitatory Synapse Development  by O'Sullivan, Matthew L. et al.
Neuron
ReportFLRT Proteins Are Endogenous Latrophilin Ligands
and Regulate Excitatory Synapse Development
Matthew L. O’Sullivan,1,5 Joris de Wit,1,5 Jeffrey N. Savas,2 Davide Comoletti,3 Stefanie Otto-Hitt,1,6
John R. Yates III,2 and Anirvan Ghosh1,4,*
1Neurobiology Section, Division of Biology, University of California San Diego, La Jolla, CA 92093, USA
2Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037, USA
3Child Health Institute of New Jersey and Department of Neuroscience and Cell Biology, UMDNJ/Robert Wood Johnson Medical School,
New Brunswick, NJ 08901, USA
4CNS Discovery, F. Hoffmann-La Roche, 4070 Basel, Switzerland
5These authors contributed equally to this work
6Present address: Department of Natural Sciences, Carroll College, Helena, MT 59625, USA
*Correspondence: aghosh@ucsd.edu
DOI 10.1016/j.neuron.2012.01.018SUMMARY
Latrophilins (LPHNs) are a small family of G protein-
coupled receptors known to mediate the massive
synaptic exocytosis caused by the black widow
spider venom a-latrotoxin, but their endogenous
ligands and function remain unclear. Mutations in
LPHN3 are strongly associated with attention deficit
hyperactivity disorder, suggesting a role for latrophi-
lins in human cognitive function. Using affinity chro-
matography and mass spectrometry, we identify
the FLRT family of leucine-rich repeat transmem-
brane proteins as endogenous postsynaptic ligands
for latrophilins. We demonstrate that the FLRT3 and
LPHN3 ectodomains interact with high affinity in
trans and that interference with this interaction using
soluble recombinant LPHN3, LPHN3 shRNA, or
FLRT3 shRNA reduces excitatory synapse density
in cultured neurons. In addition, reducing FLRT3
levels with shRNA in vivo decreases afferent input
strength and dendritic spine number in dentate
granule cells. These observations indicate that
LPHN3 and its ligand FLRT3 play an important role
in glutamatergic synapse development.
INTRODUCTION
Latrophilins (LPHNs) have long been known to mediate the
potent exocytotic effect that the black widow spider venom
a-latrotoxin exerts on synaptic terminals (Krasnoperov et al.,
1997; Lelianova et al., 1997). The latrophilin family consists of
three isoforms, LPHN1-3, encoded by different genes, with
Lphn1 and Lphn3 expression largely restricted to the CNS
(Ichtchenko et al., 1999; Sugita et al., 1998). All three LPHNs
have a similar domain organization, consisting of a G protein-
coupled receptor (GPCR) subunit and an unusually large
adhesion-like extracellular N-terminal fragment (NTF) with lec-
tin, olfactomedin, and hormone receptor domains. Thoughmuch effort has been expended investigating the mechanisms
of a-latrotoxin action (Su¨dhof, 2001), nothing is known about
the endogenous function of latrophilins in vertebrates. Further
evidence for the importance of latrophilins in the proper
functioning of neural circuits comes from recent human
genetics studies that have linked LPHN3 mutations to attention
deficit hyperactivity disorder (ADHD), a common and highly
heritable developmental psychiatric disorder (Arcos-Burgos
et al., 2010; Domene´ et al., 2011; Jain et al., 2011; Ribase´s
et al., 2011).
Here we report the identification of fibronectin leucine-rich
repeat transmembrane (FLRT) proteins as endogenous ligands
for latrophilins. There are three FLRT isoforms encoded by
different genes, Flrt1-3, that each encode single-pass trans-
membrane proteins with ten extracellular leucine-rich repeat
(LRR) domains and a juxtamembrane fibronectin type 3 (FN3)
domain (Lacy et al., 1999). FLRTs are expressed inmany tissues,
including brain, where the different isoforms have striking cell-
type-specific expression patterns in the hippocampus and
cortex (Allen Mouse Brain Atlas, 2009). FLRTs have recently
been reported to function in axon guidance and cell migration
through an interaction with Unc5 proteins (Yamagishi et al.,
2011), but they have no known role at synapses.
We report the identification of FLRT3 and LPHN3 as a synaptic
ligand-receptor pair. This interaction is of high affinity, can occur
in trans, and is mediated by the extracellular domains of FLRT3
and LPHN3. Moreover, we present evidence that FLRT3 and
LPHN3 regulate excitatory synapse number in vitro and in vivo.
These results demonstrate a role for LPHN3 and its ligand
FLRT3 in the development of synaptic circuits.RESULTS
Identification of FLRTs as Candidate LPHN Ligands
To identify candidate LPHN ligands, we used recombinant ecto-
LPHN3-Fc protein (Figure 1A) to identify putative binding
proteins from 3-week-old rat synaptosome extracts by affinity
chromatography. Proteins bound to ecto-LPHN3-Fc were
analyzed by shotgun mass spectrometry (de Wit et al., 2009;
Savas et al., 2011). Of the proteins that bound selectively toNeuron 73, 903–910, March 8, 2012 ª2012 Elsevier Inc. 903
Figure 1. Identification of FLRT3 as an
Endogenous Ligand for LPHN3
(A) Coomassie-stained SDS-PAGE gels showing
ecto-LPHN3-Fc (left) and ecto-FLRT3-Fc (right)
purified proteins running as single bands. (B and
C) Number of distinct tryptic peptides for selected
proteins detected by mass spectrometry from
ecto-LPHN3-Fc (B) or ecto-FLRT3-Fc (C) affinity
purifications. (D) Frequency of detection of all
peptides (total spectra count, ‘‘spec #’’) for
proteins identified in both LPHN3 and FLRT3
affinity purifications. (E and F) Pull-downs from
whole-brain extracts with ecto-FLRT3-Fc protein
or control Fc protein. Ecto-FLRT3-Fc precipitates
LPHN3 NTF (E), but not NRXN1 (F), from brain. (G–
I) Pull-downs on lysate of HEK293 cells trans-
fected with FLRT3-myc (G), myc-LRRTM2 (H), or
LPHN3-GFP (I) using ecto-Fc or control Fc
proteins. Ecto-LPHN3-Fc precipitates FLRT3-myc
(G), but not myc-LRRTM2, from HEK cell lysate
(H). (I) Ecto-FLRT3-Fc precipitates LPHN3-GFP
NTF. (J and K) Binding of soluble ecto-LPHN3-Fc
(J) and ecto-FLRT3-Fc (K) proteins to HEK cells
expressing FLRT3 or LPHN3. Scale bar represents
10 mm. (L) Direct interaction of FLRT3 and
LPHN3 ectodomains. Fc, ecto-LPHN3-Fc, or
ecto-NRXN1b(-S4)-Fc wasmixed with FLRT3-His,
precipitated, and analyzed by western blot.
FLRT3-His only binds to ecto-LPHN3-Fc (top).
(M) Surface plasmon resonance (SPR)-based
measurement of ecto-LPHN3-Fc binding to im-
mobilized ecto-FLRT3. Each colored trace
represents the binding response for a different
concentration of ecto-LPHN3-Fc, from 1 mM to
0.45 nM in 3-fold dilutions, separated by wash and
regeneration steps. (N) Concentration-response
function of LPHN3-FLRT3 SPR binding. The KD of
the interaction is 14.7 nM.
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FLRTs Are Endogenous Ligands for Latrophilinsecto-LPHN3-Fc, FLRT2 and FLRT3 were among the most abun-
dant and were of particular interest due to similarities in domain
organization to previously identified postsynaptic organizing
molecules such as the LRRTMs (de Wit et al., 2011), which
were not detected in our purification (Figure 1B). We also identi-
fied proteins in the Teneurin family (also named ODZs), which
have recently been reported as ligands for LPHN1 (Silva et al.,
2011) (see Figure S1A available online).
Because FLRT3 was the most abundant FLRT protein
identified in the ecto-LPHN3-Fc pull-down, we carried out
complementary experiments with ecto-FLRT3-Fc to confirm
this interaction (Figures 1B and S1A). Affinity chromatography
and mass spectrometry using ecto-FLRT3-Fc resulted in the
identification of a large number of LPHN1 and LPHN3 peptides,
with relatively fewer LPHN2 peptides, but not the abundant
presynaptic organizing protein NRXN1 (Figure 1C). UNC5B
(Figure S1B), a previously reported FLRT3 interactor, was
also identified, but at much lower abundance (Karaulanov
et al., 2009; So¨llner and Wright, 2009; Yamagishi et al., 2011).904 Neuron 73, 903–910, March 8, 2012 ª2012 Elsevier Inc.When total spectra counts from proteins identified in both
purifications were compared, LPHN3 and FLRT3 stood out
clearly as the proteins most frequently detected in both purifica-
tions (with each as bait in one condition and prey in the other)
(Figure 1D). To support our mass spectrometry results, we veri-
fied the association of FLRT3 with LPHN3 by western blot in
similar ecto-Fc pull-down assays on rat brain extract and trans-
fected heterologous cell lysate (Figures 1E–1I). Together, these
findings suggest that FLRTs likely represent endogenous ligands
for latrophilins.
FLRT3 Can Directly Interact with LPHN3
To test whether FLRT3 and LPHN3 can bind to one another in
a cellular context, we expressed FLRT3-myc in HEK293 cells
and applied ecto-LPHN3-Fc or control Fc protein. We observed
strong binding of ecto-LPHN3-Fc to cells expressing FLRT3-
myc, but no binding of Fc (Figure 1J). Ecto-LPHN3-Fc did not
bind to cells expressing myc-LRRTM2 (Figure S1D), showing
that the LPHN3-FLRT3 interaction is specific. Ecto-LPHN3-Fc
Figure 2. FLRT3 Is a Postsynaptic Protein
Capable of Interacting with LPHN3 In trans
(A) In situ hybridization with antisense Flrt3
probe in horizontal sections from P7 (left) and
P14 (right) mouse brain. (B) Western blot for
FLRT3 and known synaptic proteins PSD95 and
synaptophysin (SYP) in fractionated rat brain
protein samples. Fractions, from left to right:
homogenate, postnuclear supernatant, cytosol,
crude membrane, synaptosome, detergent solu-
bilized synaptosome, postsynaptic density, and
purified postsynaptic density. (C) In dissociated
hippocampal neurons, FLRT3-myc (green) local-
izes to dendrites in a punctate fashion, partially
colocalizes with the postsynaptic marker PSD95
(red), and is closely associated with presynaptic
VGluT1 puncta (blue). (D) Hippocampal neurons
transfected with LPHN3-GFP were cocultured
with HEK cells expressing FLRT3-myc, and
transfected axons (arrowheads) were imaged
where they contacted transfected HEK cells.
LPHN3-GFP, LPHN3 NTF, and FLRT3-myc were
all enriched at axon-HEK cell contacts. Scale bars
in (C) and (D) represent 10 mm.
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FLRT2 (Figure S1D), and ecto-LPHN1-Fc bound to all FLRT iso-
forms as well (Figure S1C). Complementarily, ecto-FLRT3-Fc,
but not control Fc, bound strongly to cells expressing LPHN3-
GFP (Figure 1K). Ecto-FLRT3-Fc also bound the previously iden-
tified interactors UNC5A, UNC5B, and UNC5C, but did not bind
to NRXN1b(+ orS4)-expressing cells (data not shown). We also
confirmed that ecto-LPHN3-Fc, but not ecto-FLRT3-Fc, could
bind to cells expressing teneurin 3, confirming that LPHNs and
teneurins can indeed interact (Figure S1E). Thus, we find that
LPHNs and FLRTs strongly interact, with promiscuity between
isoforms.
To eliminate the possibility that an unknown coreceptor
present in HEK293 cells might mediate the FLRT-LPHN interac-
tion, we performed a cell-free binding assay using purified
proteins. Histidine-tagged FLRT3 and ecto-LPHN3-Fc or control
Fc proteins were mixed in solution, and the Fc proteins were
precipitated with bead-coupled protein A/G and assessed
by western blot. We found that FLRT3-His coprecipitated with
ecto-LPHN3-Fc, but not with control Fc or NRXN1b(-S4)-Fc
(Figure 1L), confirming a direct interaction between the ectodo-
mains of FLRT3 and LPHN3. To quantitatively characterize
the affinity of the FLRT3-LPHN3 interaction, we employed a
surface plasmon resonance (SPR) bioassay to measure specific
ligand-receptor binding (Figure 1M). Plotting the maximum rela-
tive response versus the ecto-LPHN3-Fc concentrations, we
calculated the dissociation constant (Kd) of the LPHN3-FLRT3
interaction to be 14.7 nM (Figure 1N), indicating a high-affinity
interaction.Neuron 73, 903–9FLRT3 Is a Postsynaptic Protein
Expressed by Specific Neuronal
Populations
To identify brain regions where FLRT3 is
likely to function, we examined Flrt3expression in the developing brain and found that Flrt3 was
highly expressed in specific neuronal populations during the first
2 postnatal weeks (Figures 2A andS2A). In the hippocampus, the
principal cell layers of the dentate gyrus (DG) and CA3 showed
strong signal, whereas Flrt3 expression was not detected in CA1.
Given its interaction with the extracellular domain of LPHNs,
we hypothesized that FLRT3 might be a postsynaptic protein.
We first employed a subcellular fractionation approach to
examine the distribution of FLRT3 across different synaptic frac-
tions (Figure 2B) and found FLRT3 to be enriched in synapto-
some and postsynaptic density (PSD) fractions, mirroring the
distribution of PSD95 and in contrast to synaptophysin, which
is excluded from PSD fractions. Next, because endogenous
FLRT3 could not be detected by immunofluorescence with
currently available antibodies, we expressed FLRT3-myc in
dissociated hippocampal neurons and examined its subcellular
distribution. FLRT3-myc was found in dendrites in puncta that
partially colocalized with glutamatergic but not GABAergic
synapses (Figure 2C and S2C). Together, these results suggest
that FLRT3 is a postsynaptic protein of glutamatergic synapses.
LPHN3 Can Interact with FLRT3 In trans
As a putative trans-synaptic complex, FLRT3 and LPHN3 must
be able to interact across sites of cell-cell contact. We tested
whether LPHN3 and FLRT3 can interact in trans by overexpress-
ing LPHN3-GFP in dissociated hippocampal neurons and cocul-
turing them with HEK293 cells expressing FLRT3-myc or
a control construct. Strong axonal clustering of the GPCR
and NTF fragments of LPHN3, as well as enrichment of10, March 8, 2012 ª2012 Elsevier Inc. 905
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FLRTs Are Endogenous Ligands for LatrophilinsFLRT3-myc, were observed at sites of contact with FLRT3-myc-
expressing HEK293 cells (Figure 2D). No clustering of LPHN3-
GFP was observed when axons contacted control cells (data
not shown). The accumulation of FLRT3 at sites of contact with
LPHN3-expressing axons (Figure 2D) demonstrates that FLRT3
is capable of interacting in trans with axonal LPHN3 and that
the interaction can mediate mutual recruitment or retention.
To test whether FLRT3 and LPHN3 are sufficient to induce
pre- and postsynaptic differentiation, respectively, we cocul-
tured neurons with HEK293 cells expressing FLRT3 or LPHN3.
We found that FLRT3 was not sufficient to induce clustering of
synapsin in axons in this heterologous cell assay (Figures S2D
and S2E) but that LPHN3-expressing HEK293 cells did cluster
PSD95 in contacting dendrites, though less potently than
NRXN1b(-S4) (Figures S2F and S2G).
FLRT3 and LPHN3 Regulate Glutamatergic Synapse
Density In Vitro
After establishing that the latrophilin ligand FLRT3 is expressed
in hippocampal neurons and localizes to glutamatergic
synapses, we decided to test whether the interaction of endog-
enous LPHN3 with its ligand is of functional importance. We
applied excess soluble ecto-LPHN3-Fc protein to dissociated
hippocampal cultures to competitively disrupt endogenous
LPHN3 complexes and analyzed glutamatergic synapses on
dentate granule cells (GCs) (identified by nuclear Prox1 immuno-
reactivity; Williams et al., 2011) by immunofluorescence (Fig-
ure 3A). We found that ecto-LPHN3-Fc treatment strongly
reduced the density of synaptic puncta (Figure 3B) without
affecting their size (Figure 3C). These results suggest that
reducing the availability of LPHN3 ligands such as FLRT3
by competition with ecto-LPHN3-Fc prevents glutamatergic
synapses from developing properly.
If ecto-LPHN3-Fc exerts its effect by disrupting the interaction
of LPHN3 with FLRT3, loss of postsynaptic FLRT3 might be ex-
pected to result in a similar reduction in synapses. We designed
a short hairpin RNA (shRNA) to specifically knock down Flrt3
expression (shFlrt3) and verified its efficacy and specificity
(Figures S3A–S3C). To determine whether endogenous FLRT3
regulates synapse number, we electroporated postnatal day
0 (P0) hippocampal cultures with shFlrt3 or control plasmids to
sparsely knock down FLRT3 and analyzed synapses formed
onto GC dendrites by immunofluorescence (Figure 3D). We
observed a large decrease in the density of synapses with
shFlrt3 (Figure 3E), an effect similar to that observed with ecto-
LPHN3-Fc treatment. This decrease in synapse numberwas fully
rescued by coelectroporation with an shRNA-resistant FLRT3
construct (FLRT3*-myc) (Figures 3E and S3A). Additionally, we
saw a small decrease in the area of synaptic puncta following
FLRT3 knockdown (Figure 3F). To see whether the decrease in
synapse density assessed by immunofluorescence corresponds
to a decrease in functional synapses, we recorded miniature
excitatory postsynaptic currents (mEPSCs) from putative GCs
in similar cultures (Figure 3G). Consistent with the reduction in
synaptic puncta density, we found amarked decrease inmEPSC
frequency (Figure 3H) and a slight decrease in the mean ampli-
tude of mEPSCs (Figure 3I) after FLRT3 knockdown. These
experiments together suggest that a loss of FLRT3 in postsyn-906 Neuron 73, 903–910, March 8, 2012 ª2012 Elsevier Inc.aptic GCs reduces the number of excitatory synapses onto those
neurons.
If LPHN3 is involved in promoting the number of glutamatergic
synapses, as suggested by our dominant-negative experiment
with ecto-LPHN3-Fc (Figures 3A–3C), then loss of presynaptic
LPHN3 should also reduce synapse number. To test this predi-
cation, we infected hippocampal cultures with a lentivirus
expressing an shRNA against LPHN3 (shLphn3; Figure S3D)
such that the preponderance (>90%) of neurons in the culture
was transduced and recorded mEPSCs from neurons in
LPHN3 knockdown and control cultures (Figure 3J). Culture-
wide knockdown of LPHN3 reduced the frequency of mEPSCs
(Figure 3K) without affecting mEPSC amplitude (Figure 3L), sug-
gesting that loss of LPHN3 decreases the number of excitatory
synapses in these cultures.
These experiments in dissociated hippocampal cultures show
that three distinct manipulations designed to perturb LPHN3-
FLRT3 complexes—competition with ecto-LPHN3-Fc (Figures
3A–3C), shRNA knockdown of FLRT3 (Figures 3D–3I), and
shRNA knockdown of LPHN3 (Figures 3J–3L)—all lead to
a reduction in the number of glutamatergic synapses, strongly
suggesting that FLRT3 and LPHN3 serve to positively regulate
synapse number.
Postsynaptic FLRT3 Regulates the Function
of Glutamatergic Synapses In Vivo
To test whether endogenous FLRT3 contributes to synapse
development in vivo, we first used in utero electroporation to
sparsely label and manipulate DG GCs for anatomical analysis.
In fixed slices from P14 electroporated mice, GFP-filled GC
dendrites in the middle molecular layer were imaged on a
confocal microscope, and dendritic spines were counted (Fig-
ure 4A). Knockdown of FLRT3 resulted in a highly significant
reduction in dendritic protrusion density relative to controls
(Figure 4B). The density of spines on the apical dendrites of elec-
troporated CA1 pyramidal neurons, which do not express Flrt3
(Figure 2A), did not differ between shFlrt3 and control cells
(Figures 4C and 4D), functionally confirming the specificity of
the shRNA used.
To determine whether the reduction in GC dendritic spine
density reflects a decrease in the strength of synaptic input
onto these cells, we stereotaxically injected shFlrt3 or control
lentivirus into the hippocampus of P5 rat pups and cut acute
slices for electrophysiology between P13 and P16. Infected
GCs were identified by GFP epifluorescence, and simultaneous
whole-cell voltage-clamp recordings were made from nearby in-
fected and uninfected cells while perforant path synaptic inputs
were evoked from the middle molecular layer. We observed that
AMPAR-mediated EPSCs onto shFlrt3-infected neurons were
strongly reduced in amplitude relative to simultaneously re-
corded uninfected control cells (Figures 4E and 4F). NMDAR-
mediated EPSCs,measured 50ms after the stimulus at a holding
potential of +40 mV, were similarly reduced by FLRT3 knock-
down (Figures 4G and 4H). This reduction was proportional,
because the ratio of AMPAR EPSC to NMDAR EPSC for each
input was not affected by FLRT3 knockdown (Figure 4I), consis-
tent with a reduction in number of synapses rather than a selec-
tive loss of certain glutamate receptors. GCs infected with a
Figure 3. FLRT3 and LPHN3 Regulate Glu-
tamatergic Synapse Number
(A) Competitive disruption of endogenous LPHN
interactions with ecto-LPHN3-Fc reduces excit-
atory synapse density. Hippocampal cultures
were fixed and immunostained for VGluT1 (green),
PSD95 (red), and GFP (blue) at 14 days in vitro
after 6 days of treatment with 10 mg/ml Fc (left) or
ecto-LPHN3-Fc (right). (B) LPHN3-Fc treatment
reduces the density of colocalized VGluT1 and
PSD95 puncta on dendrites of identified GCs (Fc
1.00 ± 0.05, n = 17; LPHN3-Fc 0.68 ± 0.06, n = 14;
p = 0.01). All summary statistics are reported and
displayed asmean ± SEM. (C) Synaptic puncta did
not significantly differ in size between Fc- and
ecto-LPHN3-Fc-treated neurons (Fc 1.00 ± 0.04,
n = 17; LPHN3-Fc 0.90 ± 0.08, n = 14; not signifi-
cant [NS]). (D) Hippocampal neurons were elec-
troporated with GFP control plasmid (GFP),
a plasmid encoding shFlrt3 and GFP (shFlrt3), or
the shFlrt3 plasmid plus an shFlrt3-resistant
FLRT3-myc expression construct (Rescue) and
were processed for immunofluorescence as in (A).
(E) Synapse density was reduced by shFlrt3 and
returned to control levels in the rescue condition
(GFP 1.00 ± 0.08, n = 35; shFlrt3 0.66 ± 0.06, n =
33; rescue 0.96 ± 0.09, n = 34; analysis of variance
[ANOVA] p < 0.01, significant post hoc compari-
sons shown on graph). (F) Synapse area was
slightly reduced by shFlrt3 (GFP 1.00 ± 0.05, n =
35; shFlrt3 0.83 ± 0.04, n = 33; rescue 0.98 ± 0.06,
n = 34; ANOVA p < 0.05, significant post hoc
comparisons shown on graph). (G) Example
mEPSC traces recorded from cultured hippo-
campal neurons electroporated with GFP (black)
or shFlrt3 (red) plasmids. (H) Summary of mEPSC
frequencies plotted as cumulative probability
distributions of interevent intervals (IEIs) for GFP
(black) or shFlrt3 (red) electroporated cells. Inset:
quantification of mean mEPSC IEIs. shFlrt3 cells
have longer mean IEIs than control neurons (GFP
1028 ± 147 ms, n = 15; shFlrt3 3069 ± 688 ms, n =
15; p < 0.01). (I) Summary of mEPSC amplitude
plotted as cumulative probability distributions for
GFP (black) or shFlrt3 (red) electroporated cells.
Inset: quantification of mean mEPSC amplitude.
shFlrt3 electroporated cells show a small
decrease in mean mEPSC amplitude (GFP 16.4 ± 1.2 pA, n = 15; shFlrt3 12.8 ± 0.7 pA, n = 15; p < 0.05). (J) mEPSCs were recorded from neurons in hippocampal
cultures densely infected with GFP (black) or shLphn3 (red) lentiviruses such that greater than 90% of neurons were transduced. (K) shLphn3 causes a shift
toward longer times in the distribution of IEIs (GFP 745 ± 125ms, n = 19; shLphn3 1254 ± 219ms, n = 17; p < 0.05). (L) shLphn3 does not affect mEPSC amplitudes
(GFP 27.7 ± 2.6 pA, n = 19; shLphn3 28.4 ± 2.3 pA, n = 17; NS). Scale bars in (A) and (D) represent 10 mm.
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FLRTs Are Endogenous Ligands for Latrophilinscontrol lentivirus did not differ from uninfected cells by any
of these measures (Figures S4A–S4D; de Wit et al., 2009).
When we recorded mEPSCs from infected GCs we found no
difference in mEPSC amplitudes and a trend toward reduction
in frequency that did not reach significance (Figures S4E–S4G),
also suggesting that loss of FLRT3 does not affect the strength
of single synapses. Furthermore, the paired-pulse ratio of EPSCs
evoked at 20 Hz was unaffected (Figure 4J). These results indi-
cate that loss of FLRT3 leads to an attenuation of the strength
of glutamatergic transmission from the perforant path onto
GCsand a reduction in the number ofGCdendritic spines, further
supporting a role for FLRT3 in regulating synapse formation
onto GCs.DISCUSSION
Latrophilins have garnered much interest because of their role in
a-latrotoxin-stimulated neurotransmitter release, but their
endogenous functions have until now remained unknown. Here
we report that the single-pass transmembrane proteins of the
FLRT family, FLRT1-3, are endogenous ligands for LPHN1 and
LPHN3. These interactions are mediated by the N-terminal frag-
ment of LPHNs and the extracellular domain of FLRTs and are
promiscuous among isoforms. The high-affinity interaction
between LPHN3 and FLRT3, together with the postsynaptic
enrichment of FLRT3, suggests that LPHN3 and FLRT3 form a
trans-synaptic complex (Figure 4K).Neuron 73, 903–910, March 8, 2012 ª2012 Elsevier Inc. 907
Figure 4. FLRT3 Regulates Perforant Path Synapses onto Dentate Granule Cells In Vivo
(A–D) Mouse embryos were electroporated in utero with GFP or shFlrt3 plasmids at E15 and GFP-expressing dendrites imaged at P14–16. (A) Dendrites of
electroporated GCs were imaged in the middle molecular layer (MML) of the DG. (B) Flrt3 shRNA significantly reduces the density of dendritic protrusions
(GFP 2.01 ± 0.07 protrusions/mm, n = 13; shFlrt3 1.60 ± 0.07 protrusions/mm, n = 10; p < 0.001). All summary statistics are reported asmean ± SEM. (C) Dendrites
of electroporated CA1 pyramidal neurons, which do not express Flrt3, were imaged in the stratum radiatum. (D) Flrt3 shRNA does not affect the density of
dendritic protrusions in CA1 (GFP 0.87 ± 0.06 protrusions/mm, n = 8; shFlrt3 0.91 ± 0.04 protrusions/mm, n = 8; NS). (E–J) P5 rat pups were stereotaxically injected
with shFlrt3 lentivirus, and acute sliceswere cut at P13–16 for recording. (E) Simultaneouswhole-cell voltage-clamp recordings of evoked perforant path AMPAR-
mediated EPSCs onto shFlrt3 infected and uninfected DG GCs. Scatterplot shows mean EPSC amplitude from individual experiments. Inset: example average
evoked AMPAR-EPSCs recorded simultaneously from shFlrt3 infected (red) and uninfected (black) GCs. (F) shFlrt3 significantly reduces the amplitude of
AMPAR-EPSCs (shFlrt3 101.1 ± 13.4 pA; uninfected 162.8 ± 15.0 pA, n = 15; p < 0.01). (G) Evoked NMDAR-EPSCs were measured simultaneously in shFlrt3
infected (red) and uninfected (black) GCs. Inset: example average evoked NMDAR-EPSCs. The NMDAR-EPSCmeasurement was taken at the time indicated by
the arrow. (H) shFlrt3 significantly reduces the amplitude of NMDAR-mediated EPSCs (shFlrt3 129.6 ± 23.9 pA; uninfected 193.7 ± 16.9 pA, n = 0; p < 0.05).
(I) shFlrt3 does not affect the ratio of AMPAR-EPSCs to NMDAR-EPSCs at single inputs (shFlrt3 0.76 ± 0.07; uninfected 0.83 ± 0.09, n = 10; NS). (J) shFlrt3 does
not affect the ratio of EPSC amplitudes evoked by pairs of stimuli delivered at 20 Hz (EPSC2/EPSC1) (shFlrt3 1.01 ± 0.07; uninfected 1.04 ± 0.08, n = 13; NS).
(K) Schematic of proposed FLRT3-LPHN3 synaptic interaction. FLRT3 is located at postsynaptic sites and interacts trans-synaptically with the NTF of LPHN3 via
its extracellular domain. This interaction promotes synaptic development, and its disruption reduces synapse number. Scale bars in (A) and (C) represent 5 mm.
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FLRTs Are Endogenous Ligands for LatrophilinsThe resemblance of FLRTs to characterized LRR-containing
synaptic organizers (de Wit et al., 2011) suggested to us that
the trans-synaptic interaction of LPHN with FLRT might regulate
synaptic development and function. Consistent with this hypoth-
esis, we observed that three separate manipulations targeting
the LPHN3-FLRT3 complex reduce excitatory synapse number
in cultured neurons (Figure 3). We further show that loss of
FLRT3 in vivo by lentivirus-mediated shRNA knockdown
reduces the strength of evoked perforant path synaptic inputs
onto dentate GCs and the number of dendritic spines. Our
results suggest that FLRT3 may primarily regulate synapse
number, whereas LRRTM2 may regulate synapse function by908 Neuron 73, 903–910, March 8, 2012 ª2012 Elsevier Inc.controlling AMPAR recruitment (de Wit et al., 2009; see also
Soler-Llavina et al., 2011). Thus, FLRT-LPHN and LRRTM-
NRXN complexes, along with others, may regulate distinct
aspects of synapses.
How FLRTs signal postsynaptically is not known, but cis inter-
actions of FLRTs have been reported in other systems. FLRT3
interacts with FGFRs and can regulate FGF signaling (Bo¨ttcher
et al., 2004; Wheldon et al., 2010) and may also be capable of
modulating cadherin- and protocadherin-mediated cell adhe-
sion by signaling intracellularly through the small GTPase Rnd1
(Chen et al., 2009; Karaulanov et al., 2009). Both FGF signaling
(Umemori et al., 2004; Terauchi et al., 2010) and cadherin
Neuron
FLRTs Are Endogenous Ligands for Latrophilinsadhesion (Takeichi, 2007; Williams et al., 2011) are known to
influence synapse development, making them two possible
effectors for the postsynaptic action of FLRT3.
Further work is required to clarify the immediate presynaptic
molecular and cell-biological consequences of FLRT binding to
LPHN. Binding may activate downstream signaling or serve
primarily to stabilize LPHN at appropriate presynaptic sites.
Ligand binding to LPHNs may result in Ca2+ elevations through
G protein signaling and IP3-mediated calcium release from the
endoplasmic reticulum (ER), as has been shown to occur in
response to a-LTX binding (Davletov et al., 1998; Ichtchenko
et al., 1998). That we observe FLRT-induced accumulation of
both the LPHN3 NTF and GPCR domains (Figure 2D) may also
provide a hint of mechanism. Latrophilins are constitutively
cleaved into two subunits (Krasnoperov et al., 2002; Silva
et al., 2009), and it has been suggested that the association
between subunits may be dynamically regulated by ligand
binding to modulate latrophilin G protein signaling. This raises
the possibility that FLRT binding to the LPHN NTF may lead to
reassociation of the LPHN subunits and engender subsequent
G protein signaling. Whether binding of FLRTs and teneurins to
LPHNs induces similar signaling or has different functional
consequences remains to be explored.
Interestingly, FLRTs have also recently been shown to function
in axon guidance during embryonic development by interacting
with axonal Unc5 proteins (Yamagishi et al., 2011). This function
is potentially non-cell-autonomous, given that it is proposed to
depend upon proteolytically cleaved, soluble FLRT ectodomains
acting as diffusible cues. Our manipulations of FLRT3 in vivo
were sparse and, for viral experiments, began at a developmental
stage at which axon guidance was complete, suggesting that the
effects we see of FLRT3 on synapses are cell autonomous and
are not the result of axon guidance defects. Thus, an early,
non-cell-autonomous FLRT-Unc5 interaction may mediate
axon guidance, and a later, cell-autonomous FLRT-LPHN inter-
action may regulate synaptic maturation and function. This dual
function is reminiscent of the manner in which semaphorins
(Pasterkamp and Giger, 2009) and Ephs/Ephrins (Klein, 2009)
function in both axon guidance and synaptogenesis.
Although Lphn1 and Lphn3 are broadly expressed in the brain,
Flrt2 and Flrt3 show striking cell-type-specific expression
patterns, with complementary and nonoverlapping expression
in the hippocampus. Thus, although binding is possible between
all LPHNs and all FLRTs, it may be that only a certain combina-
tion of LPHNs and FLRTs is present at any given synapse. Due to
a lack of suitable antibodies, we do not know whether FLRTs are
present at all synapses on cells that express them or whether
only a subset of synapses is FLRT positive. Similarly, whether
FLRT2 and FLRT3 exert the same effect on synapses that
contain them, and how FLRT2 and FLRT3 are allocated to
synapses in cells that express both (e.g., L2/3 cortical pyramidal
neurons), are questions that will require further investigation.
Based on their expression patterns, we propose that latrophilins
may be ubiquitous presynaptic components capable of interact-
ing with different postsynaptic ligands, namely FLRTs and ten-
eurins, to regulate synaptic connectivity. This pattern would
follow the precedent set by neurexins for widely expressed pre-
synaptic regulators interacting with structurally unrelated post-synaptic ligands at different types of synapses (Williams et al.,
2010). Understanding how the brain assembles specific types
of synapses between the correct partner cells will require con-
sideration of multiple parallel trans-synaptic signaling com-
plexes, and the latrophilin-FLRT complex is poised to be an
important unit in accomplishing this task. Given the genetic
association of LPHN3 mutations (Arcos-Burgos et al., 2010; Ar-
cos-Burgos et al., 2010; Domene´ et al., 2011; Jain et al., 2011;
Martinez et al., 2011; Ribase´s et al., 2011) and FLRT3 copy
number variations (Lionel et al., 2011) with ADHD, further charac-
terization of the FLRT3-LPHN3 complex may lead to a better
understanding of the pathology and etiology of this disorder.
EXPERIMENTAL PROCEDURES
Please see the Supplemental Experimental Procedures.
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Supplemental Information includes four figures and Supplemental Experi-
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